Sunial Shaunak and his colleague Steve Brocchini claim that their "ethical pharmaceutical" model could enable millions in poor countries to be cured of infectious diseases as well as slashing the NHS drugs bill. Here it says the process will be started in India on a clinical trial basis and will be sponsored by the Indian government. The cost of producing a new drug according to multinational companies is around $800 million. However Shaunak said that the total cost of development of their drug would be just a few million pounds. He added that the patent of the drug would be held by the Imperial College who will employ top patent lawyers to make sure that no one will block its development.
More articles can be found here."